跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VARITHENA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VARITHENA
Authorized
STANDARD
VARITHENA
Provensis Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c58d73f06371b0cf
Company
Provensis Ltd.
Type
Standard
Approval Details
Approval Id
c58d73f06371b0cf
Drug Approval Canada Name
VARITHENA
Product Name
VARITHENA
Status
Dormant
Status Date
2020-02-28
Original Market Date
2016-11-30
Din
02444267
Drug Class
Human
Dosage Form
Foam
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:16.00
Atc Original
C05BB02 POLIDOCANOL
Atc Name
c 05 bb 02
Aig Number
0157210001
Company Name
Provensis Ltd.
Company Address
Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey, United Kingdom, GU9 8QL
Company Detail Path
/organization/provensis-ltd
Company Information
Pharmaceutical Company Name
Provensis Ltd.
Name Zh
普罗文西斯有限公司
Country Name
United Kingdom
Website
https://www.bostonscientific.com/en-us/home.html
Active Ingredients
POLIDOCANOL
1.3 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c58d73f06371b0cf
Type
Standard
Back to Health Canada Approvals